TOX4 and familial pancreatic carcinoma: In head and neck cancer, the expression level of TOX4 correlated with adverse survival probability (Fig. 6B); similar patterns of association between TOX4 expression and shorter patient survival were also seen in stomach cancer, urothelial cancer, and pancreatic cancer (Fig. S5, A–C).